Rathod Aishwarya, Tandon Radhika, Vanathi Murugesan, Gupta Noopur, Lomi Neiwete, Ahmed Nishat Hussain, Beniwal Abhijeet, Gupta Deepak
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, New Delhi, India.
Department of Ocular Microbiology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, New Delhi, India.
Indian J Ophthalmol. 2025 Jul 1;73(7):1031-1037. doi: 10.4103/IJO.IJO_1899_24. Epub 2025 Apr 17.
The purpose is to compare the utilization rate and corneal graft outcomes from multiorgan donors (MDs) versus those from cadaveric donors (CDs).
In this ambispective and observational study, 36 corneas obtained from MDs and 72 corneas from their age-matched and sex-matched voluntary donors under the Hospital Cornea Retrieval Program (HCRP) from an eye bank were assessed clinically using slit lamp and under a specular microscope for their suitability for utilization. The percent utilization for keratoplasties was noted and compared between the two donor sources as the primary outcome. The transplanted corneas were followed up for 18 months for the assessment of graft survival and other outcome parameters.
The utilization rate of corneas obtained from MDs (80.6%) was significantly higher than that of corneas obtained from CDs (68.1%). The mean endothelial cell density (ECD) was significantly higher in corneas from MD as compared to those from CD ( P = 0.037) at 18 months. The Kaplan-Meier survival analysis revealed a cumulative graft failure rate over 1.5 years as 10.3% for corneas obtained from MD and 16.3% for corneas obtained from CD. The microbiological analysis of the corneoscleral rim sent intraoperatively revealed three culture-positive specimens, two from CD, and one from MD.
The donor source was a significant factor in determining the suitability of corneas for keratoplasty. Death preservation interval, cause of death, ECD, and processing had a modest influence on tissue suitability or quality. This data may help eye banks formulate policies that can maximize the procurement of corneas from MDs under HCRP.
比较多器官捐献者(MDs)与尸体捐献者(CDs)的角膜利用率及角膜移植效果。
在这项回顾性观察研究中,对眼库通过医院角膜获取项目(HCRP)从MDs获取的36只角膜以及从年龄和性别匹配的自愿捐献者获取的72只角膜进行临床评估,使用裂隙灯和角膜内皮显微镜检查其是否适合使用。记录并比较两种供体来源的角膜移植利用率作为主要结果。对移植的角膜进行18个月的随访,以评估移植存活情况和其他结果参数。
MDs获取的角膜利用率(80.6%)显著高于CDs获取的角膜(68.1%)。18个月时,MDs来源的角膜平均内皮细胞密度(ECD)显著高于CDs来源的角膜(P = 0.037)。Kaplan-Meier生存分析显示,MDs获取的角膜1.5年以上的累积移植失败率为10.3%,CDs获取的角膜为16.3%。术中送检的角膜缘微生物分析显示有3个培养阳性标本,2个来自CDs,1个来自MDs。
供体来源是决定角膜是否适合角膜移植的重要因素。死亡保存间隔、死亡原因、ECD和处理过程对组织适用性或质量有一定影响。这些数据可能有助于眼库制定政策,以最大限度地从HCRP下的MDs获取角膜。